Merck Tbk. vs Pembangunan Jaya Ancol Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Pembangunan Jaya Ancol Tbk. trades at Rp456 (market cap 739.2B, 87.8K 24h volume). The key difference: Merck Tbk. is far larger — about 2.3× Pembangunan Jaya Ancol Tbk.'s market cap, and Pembangunan Jaya Ancol Tbk. is more actively traded (87.8K versus 37.6K). Which is the better fit depends on your goals.
| MERK | PJAA | |
|---|---|---|
Market Cap | 1.7T | 739.2B |
Volume | 37.6K | 87.8K |
Lot | 376 | 878 |
Turnover | 144.47M | 40.07M |
Average Price | 3,842.23 | 456.33 |
Value | 144.47M | 40.07M |
Indicative Equilibrium Price | 3,840 | 460 |
Indicative Equilibrium Volume | 7 | 4 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Pembangunan Jaya Ancol (Company) was established base on notarial deed No. 33 of Achmad Abid SH, dated July 10, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 13 of Mrs. Aulia Taufani, S.H., dated April 01, 2004.
Read more on PJAA →